Levetiracetam Tarbis Farma

Levetiracetam, the active ingredient in Levetiracetam Tarbis Farma, is an anticonvulsant presented as an oral tablet for oral use. It is employed to treat various seizure types, including partial‑onset, generalized tonic‑clonic, and myoclonic seizures, in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Tarbis Farma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourced from the European Union market. The company ensures quality compliance with EU regulatory standards.

Levetiracetam is an antiepileptic medication used to control seizure activity in the central nervous system.

- Partial-onset seizures: reduces the frequency and severity of focal seizures. - Generalized tonic-clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases rapid muscle jerks associated with epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Blood dyscrasias: abnormal blood counts requiring monitoring. - Hepatic failure: signs of liver dysfunction such as jaundice.

Before initiating therapy, clinicians should consider several safety aspects.

- Renal impairment: adjust dose as recommended by the prescriber. - Hepatic dysfunction: monitor liver function tests regularly. - Psychiatric symptoms: observe for mood changes, depression, or agitation. - Concomitant therapy: review other antiepileptics for potential interactions. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenobarbital: may decrease levetiracetam effectiveness. - Phenytoin: may lower levetiracetam levels, compromising seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of central nervous system depression. - Alcohol: can enhance sedation and dizziness. - Other CNS depressants: monitor for additive sedative effects.